Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma [NA]

View source ↗

Summary

This clinical trial investigates whether a low-glucose/high-fat dietary regimen improves the diagnostic accuracy of 2-[18F]FDG PET/CT for lepidic-predominant lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Lepidic-Predominant Lung Adenocarcinoma, Lung Adenocarcinoma | NA | Status: RECRUITING